Apr 08

Webinar on Thursday, April 15, 4:30 – 5:30 pm, CET: BioCopy presents its innovative COVID-19 mutant mapping platform for developing new vaccines.

BioCopy will showcase in a webinar its biomolecule copier in collaboration with Sino Biological, a global leader in recombinant technology, at the Festival of Biologics USA Congress.

Dr. Pascal Brenneisen (former CEO Novartis Switzerland and Advisory Board BioCopy), Dr. Günther Proll (BioCopy Senior Scientist) and Dr. Günter Roth (CEO and founder BioCopy) will introduce the BioCopy technology, and how it is applied to enable the development of diagnostics or therapeutics for existing and future Covid-19 mutations.